Mortality among dialysis patients prescribed sevelamer hydrochloride and lanthanum carbonate compared with calcium-based phosphate binders: A retrospective cohort study using the Australian and New Zealand Dialysis and Transplant Database (ANZDATA).

Not Applicable

Active, not recruiting

• Conditions: Chronic Kidney Disease stage 5D (dialysis); All cause mortality and cardiovascular mortality; calcium and non calcium-based phosphate binders; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12613000762752
• Lead Sponsor: A/Prof Grahame Elder

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

Australian dialysis patients aged over 18 years of age and registered in ANZDATA registry will be included in the study.

Exclusion Criteria

New Zealand patients and patients aged less than 18 years of age in ANZDATA registry will be excluded

Study & Design

• Study Type: Observational
• Study Design: Not specified